These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26607596)

  • 1. Fms-like tyrosine kinase 3 (Flt3) ligand depletes erythroid island macrophages and blocks medullar erythropoiesis in the mouse.
    Jacobsen RN; Nowlan B; Brunck ME; Barbier V; Winkler IG; Levesque JP
    Exp Hematol; 2016 Mar; 44(3):207-12.e4. PubMed ID: 26607596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia.
    de Haan G; Loeffler M; Nijhof W
    Exp Hematol; 1992 Jun; 20(5):600-4. PubMed ID: 1375161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization with granulocyte colony-stimulating factor blocks medullar erythropoiesis by depleting F4/80(+)VCAM1(+)CD169(+)ER-HR3(+)Ly6G(+) erythroid island macrophages in the mouse.
    Jacobsen RN; Forristal CE; Raggatt LJ; Nowlan B; Barbier V; Kaur S; van Rooijen N; Winkler IG; Pettit AR; Levesque JP
    Exp Hematol; 2014 Jul; 42(7):547-61.e4. PubMed ID: 24721610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
    Veiby OP; Jacobsen FW; Cui L; Lyman SD; Jacobsen SE
    J Immunol; 1996 Oct; 157(7):2953-60. PubMed ID: 8816402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maea expressed by macrophages, but not erythroblasts, maintains postnatal murine bone marrow erythroblastic islands.
    Wei Q; Boulais PE; Zhang D; Pinho S; Tanaka M; Frenette PS
    Blood; 2019 Mar; 133(11):1222-1232. PubMed ID: 30674470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
    Mayani H; Guilbert LJ; Janowska-Wieczorek A
    Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages and regulation of erythropoiesis.
    Jacobsen RN; Perkins AC; Levesque JP
    Curr Opin Hematol; 2015 May; 22(3):212-9. PubMed ID: 25693142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant granulocyte colony-stimulating factor on erythropoiesis in the human fetus and neonate.
    Calhoun DA; Li Y; Christensen RD
    Pediatr Res; 1996 Dec; 40(6):872-5. PubMed ID: 8947965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging flow cytometry reveals that granulocyte colony-stimulating factor treatment causes loss of erythroblastic islands in the mouse bone marrow.
    Tay J; Bisht K; McGirr C; Millard SM; Pettit AR; Winkler IG; Levesque JP
    Exp Hematol; 2020 Feb; 82():33-42. PubMed ID: 32045657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells.
    Metcalf D; Nicola NA
    J Cell Physiol; 1983 Aug; 116(2):198-206. PubMed ID: 6602806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum flt3-ligand in healthy donors undergoing granulocyte colony-stimulating factor-induced peripheral stem cell mobilization.
    Dettke M; Jurko S; Rüger BM; Leitner G; Greinix HT; Kalhs P; Fischer MB; Höcker P
    J Hematother Stem Cell Res; 2001 Apr; 10(2):317-20. PubMed ID: 11359680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.
    Rossner MT; McArthur GA; Allen JD; Metcalf D
    Cell Growth Differ; 1994 May; 5(5):549-55. PubMed ID: 8049161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of bone marrow macrophages in regulating erythropoiesis in different states of the erythron].
    Zakahrov IuM; Rassokhin AG; Krest'ianinova OG; Efimenko GP
    Patol Fiziol Eksp Ter; 1991; (3):36-8. PubMed ID: 1923613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fms-related tyrosine kinase 3 expression discriminates hematopoietic stem cells subpopulations with differing engraftment-potential: identifying the most potent combination.
    Huang Y; Ratajczak MZ; Reca R; Xu H; Tanner M; Rezzoug F; Hussain LR; Fugier-Vivier I; Bolli R; Ildstad ST
    Transplantation; 2008 Apr; 85(8):1175-84. PubMed ID: 18431239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microfluorimetric research on the erythroblastic islands and macrophages of the bone marrow].
    Rassokhin AG; Pochinskiĭ AG; Liannoĭ KV; Ovchinnikov GA
    Biull Eksp Biol Med; 1992 Oct; 114(10):347-51. PubMed ID: 1288682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of macrophage culture supernatants on erythroblastic islets in rat erythropoiesis].
    Zakharov Y; Prenant M
    Nouv Rev Fr Hematol (1978); 1983; 25(1):17-22. PubMed ID: 6835833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.
    Stacchini A; Fubini L; Severino A; Sanavio F; Aglietta M; Piacibello W
    Leukemia; 1996 Oct; 10(10):1584-91. PubMed ID: 8847893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF impairs erythropoiesis by disrupting erythroblastic island formation via macrophages.
    Cao W; Fan W; Wang F; Zhang Y; Wu G; Shi X; Shi JX; Gao F; Yan M; Guo R; Li Y; Li W; Du C; Jiang Z
    J Transl Med; 2022 Jan; 20(1):11. PubMed ID: 34980171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.